IL6R and rheumatoid arthritis: For example, the humanized anti-IL-6R antibody tocilizumab is FDA-approved for the treatment of rheumatoid arthritis, certain autoimmune disease, and severe or life-threatening CAR-T cell-induced cytokine release syndrome [61,101,102].